Conference Presentations, Acquisitions, Management Changes, and Annual Shareholders Meeting - Analyst Notes on WellCare, Tenet, Auxilium, Isis Pharmaceuticals and Mettler-Toledo

NEW YORK, June 6, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding WellCare Health Plans, Inc. (NYSE: WCG), Tenet Healthcare Corp (NYSE: THC), Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) and Mettler-Toledo International Inc. (NYSE: MTD). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3419-100free.

--
WellCare Health Plans, Inc. Analyst Notes
On June 3, 2014, WellCare Health Plans, Inc. (WellCare) announced that its CEO and Chairman of the Board, Dave Gallitano, will present at the Goldman Sachs 35th Annual Global Healthcare Conference on Tuesday, June 10, 2014, at 8:00 a.m. PT (11:00 a.m. ET). According to the Company, a live webcast of the presentation will be available at its website, where a replay of the same will also be available an hour after the presentation for 30 days. The full analyst notes on WellCare are available to download free of charge at:

http://www.analystsreview.com/Jun-06-2014/WCG/report.pdf

--
Tenet Healthcare Corp Analyst Notes
On June 3, 2014, Tenet Healthcare Corp (Tenet) reported that its subsidiary has acquired majority interest in Texas Regional Medical Center, a 70-bed hospital in Sunnyvale, Texas, located 15 miles east of downtown Dallas. According to the Company, the acquisition of Texas Regional Medical Center complements Tenet's quality services at its three other Dallas-area hospitals namely - Lake Pointe Medical Center in Rowlett, Doctors Hospital of White Rock Lake in Dallas, and Centennial Medical Center in Frisco, as well as 12 outpatient centers in the market. Trevor Fetter, Tenet's President and CEO said; "We are pleased to add Texas Regional Medical Center to our network and look forward to working with the team of loyal and high-quality medical staff to bring additional services and investment to residents in the area." The full analyst notes on Tenet are available to download free of charge at:

http://www.analystsreview.com/Jun-06-2014/THC/report.pdf

--
Auxilium Pharmaceuticals, Inc. Analyst Notes
On June 2, 2014, Auxilium Pharmaceuticals, Inc. (Auxilium) announced that CFO, James E. Fickenscher, is leaving the Company to pursue other interests. According to the Company, Mr. Fickenscher will hold his current role until August 15, 2014. Adrian Adams, CEO and President of Auxilium stated, "The Board and I want to thank Jim for his nine years of service and important contributions to the evolution of Auxilium. Over the past year, we have evolved Auxilium into a company with a leadership position in men's healthcare, and a diversified revenue stream driven by a portfolio of 12 products. We are now positioning the Company for the next phase of evolution and growth and have initiated the search for a new Chief Financial Officer. Our focus remains to execute on our visionary goals and corporate strategy and, most importantly, to deliver value to our shareholders." The full analyst notes on Auxilium are available to download free of charge at:

http://www.analystsreview.com/Jun-06-2014/AUXL/report.pdf

--
Isis Pharmaceuticals, Inc. Analyst Notes
On June 3, 2014, Isis Pharmaceuticals, Inc. (Isis Pharmaceuticals) announced that its management will present a general corporate update in conjunction with the Company's 2014 Annual Meeting of Stockholders and Open House on Tuesday, June 10, 2014, at 2:10 p.m. PT, in Carlsbad, California. The Company informed that the Annual Meeting of Stockholders will begin at 2:00 p.m. PT, followed by Corporate Presentation at 2:10 p.m. PT, and Open House at 3:00 p.m. PT. According to the Company, a live audio webcast of the presentation can be accessed through its website under the Investors & Media section. A replay of the same will also be available at the said location within 48 hours after the presentation and will be archived for a limited time. The full analyst notes on Isis Pharmaceuticals are available to download free of charge at:

http://www.analystsreview.com/Jun-06-2014/ISIS/report.pdf

--
Mettler-Toledo International Inc. Analyst Notes
On June 3, 2014, Mettler-Toledo International Inc. (Mettler-Toledo) announced that it will present at the Goldman Sachs Global Healthcare Conference on Tuesday, June 10, 2014, at 3:20 p.m. PT (6:20 p.m. ET), in Rancho Palos Verdes in California. Mettler-Toledo stated that a live webcast of the presentation can be accessed through the investor relations page of the Company's website, and a replay of the webcast will be available at the said location for 7 days. The full analyst notes on Mettler-Toledo are available to download free of charge at:

http://www.analystsreview.com/Jun-06-2014/MTD/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review